Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.

In this overview we review and model how radiotherapy tumour control and complication rates vary with dose, fractionation, schedule duration, irradiated volume and use of chemotherapy for stage III non-small cell lung cancer (NSCLC), and use the modelling to study the effectiveness of different NSCL...

Full description

Bibliographic Details
Main Authors:	Fenwick, J, Nahum, A, Malik, Z, Eswar, C, Hatton, M, Laurence, V, Lester, J, Landau, D
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
by: Panettieri, V, et al.
Published: (2010)

UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
by: Hughes, S, et al.
Published: (2007)

A phase I/II trial of concurrent chemo-radiation with dose-escalated radiotherapy in patients with stage II or stage III non-small cell lung cancer
by: Landau, D, et al.
Published: (2013)

Dose-individualisation for lung cancer radiotherapy - are we ready?
by: Malik, Z, et al.
Published: (2007)

ISO-NTCP customisation of the prescription dose in lung-tumour radiotherapy
by: Malik, Z, et al.
Published: (2007)

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
by: Warren, S, et al.
Published: (2014)

The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer
by: Lester, J, et al.
Published: (2012)

Radiation dose escalation in stage III non-small-cell lung cancer.
by: William Thomas Sause, et al.
Published: (2011-11-01)

Biomathematical model-based analysis of a standard UK dose and fractionation lung tumour radiotherapy protocol
by: Malik, Z, et al.
Published: (2007)

Using a Monte Carlo model to predict dosimetric properties of small radiotherapy photon fields.
by: Scott, A, et al.
Published: (2008)

Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
by: Hanna Grzbiela, et al.
Published: (2023-11-01)

A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer
by: Ma Li, et al.
Published: (2019-03-01)

Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer
by: Mackenzie, J, et al.
Published: (2011)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
by: E. P. Solov’eva, et al.
Published: (2016-02-01)

Numerical Study of Effects of Bladder Filling on Prostate Positioning In Radiotherapy
by: Krywonos, J, et al.
Published: (2009)

The impact of cardiac radiation dosimetry on survival following radiotherapy for non-small cell lung cancer
by: Vivekanandan, S, et al.
Published: (2017)

Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.
by: Fenwick, J, et al.
Published: (2012)

Impact of schedule duration on head and neck radiotherapy: Accelerated tumor repopulation versus compensatory mucosal proliferation
by: Fenwick, J, et al.
Published: (2012)

Isotoxic dose escalation with real-time imaging on an MR-linac in lung radiation therapy
by: Bendall, L, et al.
Published: (2018)

Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer.
by: Brock, J, et al.
Published: (2008)

Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs
by: Bendall, L, et al.
Published: (2018)

Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.
by: Fenwick, J, et al.
Published: (2008)

Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
by: Guckenberger, M, et al.
Published: (2012)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
by: Wenrui Chen MS, et al.
Published: (2022-12-01)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
by: Huanhuan Li, et al.
Published: (2023-08-01)

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
by: Chaoyuan Liu, et al.
Published: (2023-06-01)

DOSE-ESCALATED EXTERNAL BEAM RADIOTHERAPY DURING HORMONO-RADIOTHERAPY FOR PROSTATE CANCER
by: Yu. V. Gumenetskaya, et al.
Published: (2016-07-01)

Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC
by: Vivekanandan, S, et al.
Published: (2017)

Thermal ablation versus radiotherapy for inoperable stage III non-small cell lung cancer: a propensity score matching analysis
by: Wei-Yu Yang, et al.
Published: (2023-12-01)

Preliminary exploration of response the course of radiotherapy for stage III non-small cell lung cancer based on longitudinal CT radiomics features
by: Ruiping Zhang, et al.
Published: (2022-01-01)

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
by: Paul Martin Putora, et al.
Published: (2020-02-01)

Characterizing the influence of detector density on dosimeter response in non-equilibrium small photon fields.
by: Scott, A, et al.
Published: (2012)

18F-FLT PET/CT Sequential Imaging to Quantify Tumour Proliferation During Radiotherapy in Patients With Lung and Head and Neck Cancer
by: Chalkidou, A, et al.
Published: (2011)

18F-FLT PET/CT sequential imaging to quantify tumour proliferation during radiotherapy in patients with lung and head and neck cancer.
by: Chalkidou, A, et al.
Published: (2011)

Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer
by: Ruiyang Wang MB, et al.
Published: (2023-05-01)

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy
by: Emily S. Lebow, et al.
Published: (2023-09-01)

Value of carbon-ion radiotherapy for early stage non-small cell lung cancer
by: Juan Xiong, et al.
Published: (2022-09-01)

The Role of Postoperative Radiotherapy on Stage N2 Non-small Cell Lung Cancer
by: Fangfang DU, et al.
Published: (2009-11-01)

Tracheoesophageal fistula closure after staged dose-escalated radiotherapy for esophageal squamous cell carcinoma: a case report
by: Chan-jun Zhen, et al.
Published: (2023-05-01)

Monte Carlo modeling of small photon fields: quantifying the impact of focal spot size on source occlusion and output factors, and exploring miniphantom design for small-field measurements.
by: Scott, A, et al.
Published: (2009)